Author:
Tanaka Tsuyoshi,Kinoshita Yoshihiro,Udagawa Harushi,Ueno Masaki,Ehara Kazuhisa,Haruta Shusuke,Kaida Sachiko,Nakagawa Masatoshi
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part I Edited by the Japan Esophageal Society. Esophagus. 2008;5:61–73.
2. Kuwano H, Nishimura Y, Ohtsu A, Kato H, Kitagawa Y, Tamai S, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2007 edition: part II Edited by the Japan Esophageal Society. Esophagus. 2008;5:117–32.
3. Ando N, Kato H, Igaki H, Shinoda M, Ozawa S, Shimizu H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2011. [Epub ahead of print] PMID: 21879261.
4. Matsutani T, Sasajima K, Maruyama H, Futami R, Tsuchiya Y, Kashiwabara M, et al. Evaluation of second-line chemotherapy with docetaxel/5-fluorouracil/cisplatin for unresectable or recurrent squamous cell carcinoma of the esophagus. Jpn J Gastroenterol Surg. 2008;41:458–63 (in Japanese with English abstract).
5. Minamide J, Aoyama N, Takada K, Oota Y. Evaluation of docetaxel, CDDP and 5-FU combined therapy as second-line chemotherapy for esophagus cancer. Gan To Kagaku Ryoho. 2007;34(1):49–52 (in Japanese with English abstract).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献